Prevention of Alzheimer's Disease and Cognitive Decline with Diet and Lifestyle: Proceedings of the A. G. Leventis Foundation Conference.
Alzheimer’s Disease
Mediterranean diet
cognitive decline
diet
lifestyle
olive oil
prevention
public health
Journal
The journal of prevention of Alzheimer's disease
ISSN: 2426-0266
Titre abrégé: J Prev Alzheimers Dis
Pays: Switzerland
ID NLM: 101638820
Informations de publication
Date de publication:
2023
2023
Historique:
entrez:
15
1
2023
pubmed:
16
1
2023
medline:
18
1
2023
Statut:
ppublish
Résumé
The A. G. Leventis Foundation International Conference, "Prevention of Alzheimer's Disease and Cognitive Decline with Diet and Lifestyle", was held on May 11-12th, 2022 in Nicosia, Cyprus. This conference examined the role of diet and lifestyle for the prevention and treatment of Alzheimer's Disease and other forms of cognitive decline. Speakers from leading academic institutions presented evidence on healthy dietary patterns, with a particular focus on the traditional Mediterranean diet (MedDiet), in association with cognitive outcomes, mainly cognitive decline, dementia, and Alzheimer's disease, from both observational and interventional studies. Moreover, future directions for the potential use of olive oil, rich in polyphenols, for its therapeutic use as a nutraceutical, as well as nutritional interventions with high-quality dietary patterns (i.e. MedDiet) that support existing primarily observational evidence for the prevention of cognitive decline, as well as challenges in designing rigorous clinical trials are summarized and discussed within the conference proceedings.
Identifiants
pubmed: 36641619
doi: 10.14283/jpad.2022.99
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-143Déclaration de conflit d'intérêts
M.S.H, M.S.P, S.A, A.H, P.M, M.A.M, and M.Y declare no conflict of interest to disclose. S.K. reports grants from Leventis Foundation during the conduct of the study and N.S. reports grants from Alzheimer’s Association, grants from European Social Fund, and grants from Ministry for Health Greece during the conduct of the study; personal fees from NIH, grants from EISAI, grants from EPAD, and grants from NovoNordisc outside the submitted work.